罗欣药业集团股份有限公司关于为控股子公司提供担保的进展公告

Group 1 - The company and its subsidiaries have provided guarantees exceeding 100% of the latest audited net assets, with guarantees over 50% of the company's latest audited net assets, prompting investors to pay attention to guarantee risks [2] - For the fiscal year 2025, the company plans to provide a total guarantee amount not exceeding RMB 648 million for its subsidiary, Shandong Luoxin Pharmaceutical Group Co., Ltd., with a specific guarantee amount of RMB 505 million [3][4] - The company signed a guarantee contract with Huaxia Bank for a loan of RMB 50 million for Shandong Luoxin, increasing the total guarantee balance to RMB 1,057.12 million [4] Group 2 - Shandong Luoxin Pharmaceutical Group Co., Ltd. is a subsidiary of the company, established on November 30, 2001, with a registered capital of RMB 60.96 million [5] - The company holds a 99.65% stake in Shandong Luoxin, which is not a dishonest executor and has a good credit status [5][6] - The company has provided guarantees to Shandong Luoxin without requiring counter-guarantees from minority shareholders, as it has effective control over the subsidiary [9] Group 3 - After the recent guarantee, the total guarantee amount by the company and its subsidiaries is RMB 1,868 million, which is 135.14% of the latest audited net assets [10] - The total balance of guarantees provided by the company and its subsidiaries is RMB 1,102.32 million, accounting for 79.75% of the latest audited net assets [10] - There are no overdue guarantees or guarantees involved in litigation that could result in losses for the company [10] Group 4 - The company approved the transfer of a 20% stake in its subsidiary, Luoxin Anruowei Pharmaceutical (Chengdu) Co., Ltd., to Helix Healthcare B.V. for USD 5.125 million, reducing its stake from 70% to 50% [14] - The transfer has been completed, and the company has released all guarantees related to the bank loans for Luoxin Anruowei, with outstanding prepayments reduced from RMB 3.9737 million to RMB 0.8534 million [15]